Keyphrases
Steroid-induced Ocular Hypertension
100%
Sodium 4-phenylbutyrate
100%
Ocular Hypertension
100%
Matrix metalloproteinase-9 (MMP-9)
100%
Extracellular Matrix Deposition
100%
Phenylbutyrate
100%
Trabecular Meshwork
83%
Extracellular Matrix
66%
Trabecular Meshwork Cells
50%
Endoplasmic Reticulum Stress (ER stress)
33%
Mouse Model
33%
Intraocular Pressure
16%
Elevated Intraocular Pressure
16%
Topical Ocular
16%
Glaucoma
16%
Normal Human
16%
Extracellular Matrix Accumulation
16%
Glucocorticoid-induced
16%
Aqueous Humor Outflow
16%
Glucocorticoid Therapy
16%
Human Trabecular Meshwork
16%
Blindness
16%
MMP Activity
16%
Serious Adverse Effects
16%
Eye Drops
16%
Chemical Chaperone
16%
Minocycline
16%
Small Molecule Compounds
16%
Chemical Inhibitors
16%
Chaperone Activity
16%
Non-contractile Tissue
16%
Matrix Reduction
16%
Medicine and Dentistry
Trabecular Meshwork
100%
Extracellular Matrix
100%
Ocular Hypertension
100%
Gelatinase B
100%
Sodium Phenylbutyrate
100%
Glucocorticoid
88%
Arylbutyric Acid Derivative
66%
Intraocular Pressure
22%
Endoplasmic Reticulum Stress
22%
Ex Vivo
11%
Chaperone
11%
Glaucoma
11%
Aqueous Humor Outflow
11%
Adverse Event
11%
Corticosteroid Therapy
11%
Minocycline
11%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Phenylbutyrate
100%
Glucocorticoid
100%
Intraocular Hypertension
100%
Gelatinase B
100%
Arylbutyric Acid Derivative
75%
Mouse Model
25%
Glaucoma
12%
Adverse Event
12%
Chaperone
12%
Normal Human
12%
Minocycline
12%
Biochemistry, Genetics and Molecular Biology
Gelatinase B
100%
MMP9
100%
Glucocorticoid
100%
Endoplasmic Reticulum Stress
25%
Intraocular Pressure
25%
Mouse Model
25%
Normal Human
12%
Aqueous Humor Outflow
12%
Chemical Chaperone
12%